BA
PFE icon

Bridgewater Advisors’s Pfizer PFE Stock Holding History

Bridgewater Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
62,287
-5,353
-8% -$140K 0.08% 113
2026
Q1 		$1.76M Buy
67,640
+2,450
+4% +$65.2K 0.1% 93
2025
Q4 		$1.66M Sell
65,190
-1,005
-2% -$25.3K 0.11% 92
2025
Q3 		$1.6M Buy
66,195
+1,442
+2% +$35.6K 0.11% 89
2025
Q2 		$1.55M Sell
64,753
-840
-1% -$19.6K 0.12% 92
2025
Q1 		$1.56M Sell
65,593
-306
-0.5% -$8.01K 0.14% 88
2024
Q4 		$1.74M Sell
65,899
-2,777
-4% -$75.3K 0.18% 67
2024
Q3 		$1.95M Sell
68,676
-76
-0.1% -$2.22K 0.2% 64
2024
Q2 		$2.07M Buy
68,752
+4,779
+7% +$132K 0.26% 58
2024
Q1 		$1.78M Sell
63,973
-4,864
-7% -$135K 0.27% 58
2023
Q4 		$1.98M Buy
68,837
+180
+0.3% +$5.44K 0.3% 50
2023
Q3 		$2.28M Sell
68,657
-316
-0.5% -$11.2K 0.37% 43
2023
Q2 		$2.53M Sell
68,973
-84
-0.1% -$3.27K 0.51% 38
2023
Q1 		$2.82M Sell
69,057
-117
-0.2% -$5.05K 0.61% 36
2022
Q4 		$3.54M Sell
69,174
-8,718
-11% -$418K 0.86% 26
2022
Q3 		$3.41M Buy
77,892
+10,574
+16% +$514K 0.94% 20
2022
Q2 		$3.53M Buy
67,318
+200
+0.3% +$10.2K 0.73% 21
2022
Q1 		$3.48M Buy
67,118
+164
+0.2% +$8.51K 0.84% 24
2021
Q4 		$3.95M Buy
66,954
+256
+0.4% +$12.7K 0.87% 22
2021
Q3 		$2.87M Buy
66,698
+6
+0% +$266 0.79% 29
2021
Q2 		$2.61M Buy
66,692
+968
+1% +$37.6K 0.83% 28
2021
Q1 		$2.61M Buy
+65,724
New +$2.33M 1.32% 15
2014
Q2 		$906K Sell
32,170
-67,708
-68% -$1.93M 0.76% 41
2014
Q1 		$3.04M Sell
99,878
-3,509
-3% -$105K 3.06% 6
2013
Q4 		$3M Buy
+103,387
New +$3.01M 3.09% 6

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bridgewater Advisors's PFE Position: Q2 2026 in Review

Bridgewater Advisors reduced its Pfizer (PFE) stake by 7.9% in Q2 2026, selling an estimated $140K and leaving 62,287 shares worth $1.56M. The position accounts for 0.08% of the portfolio, ranked #113.

Bridgewater Advisors first reported a position in PFE in Q4 2013 and has held it in 25 quarters since. The position peaked at $3.95M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bridgewater Advisors held 62,287 shares of Pfizer worth $1.56M as of Q2 2026.
  • Bridgewater Advisors sold 5,353 Pfizer shares in Q2 2026, an estimated $140K.
  • Pfizer made up 0.08% of Bridgewater Advisors's portfolio in Q2 2026, its #113 holding.
  • Bridgewater Advisors first reported a position in Pfizer in Q4 2013 and has held it in 25 quarters since.
  • Bridgewater Advisors's Pfizer position peaked at $3.95M in Q4 2021.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.